
Haohai Biological Technology (06826.HK) is a leading company in China focusing on R&D, manufacturing and sales of biomedical materials. We strategically target the fast-growing therapeutic areas in the biomedical materials market including ophthalmology, medical aesthetics and would healing, orthopedics, and anti-adhesion and hemostasis. We currently manufacture intraocular lens (IOL), medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF, etc. Based on the sales volume of the Company's IOL and the number of national cataract surgery cases, the Company has captured about 30% of the IOL market in the PRC. Meanwhile, the market share of Company's anti-adhesion products, OVD products and orthopedics viscosupplementation products was 49.05%, 45.93%, and 36.21%, respectively.
我们正在追踪 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 的市场扩张
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 的国际扩张与竞争对手的对比情况
条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.你 | 0 | 0 | — | 0 | 0 |
当前没有招聘
注册以跟踪该公司,并在发生变化时第一时间获得提醒。
没有进行中的营销活动
注册以跟踪该公司,并在发生变化时第一时间获得提醒。
全球水光针市场预计2032年达238亿元,年复合增长率为10.6%。市场增长由非手术美容治疗和皮肤保湿需求增加推动。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 的业务、市场和增长信号的快速解答。
